Prostate cancer
Results
Phase 1
This trial looked at combining docetaxel and rhenium 186 for prostate cancer that had spread to the bones. It recruited men whose cancer was no longer responding to hormone therapy.
Recruitment start: 10 September 2007
Recruitment end: 16 November 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof J. O’Sullivan
Belfast City Hospital HPSS Trust
Covidien Mallinckrodt
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
Sanofi
Last reviewed: 24 May 2012
CRUK internal database number: 997